Bing–Neel Syndrome: Update on Diagnosis and Treatment

Evangeline Y. Wong, Shirley D’Sa, Monique C. Minnema, Jorge J. Castillo, Dipti Talaulikar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenström macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients diagnosed with BNS. It is anticipated that further development of Bruton Tyrosine Kinase (BTK) inhibitors and less toxic chemoimmunotherapies will improve treatment delivery and response.

Original languageEnglish
Pages (from-to)758-770
Number of pages13
JournalHemato
Volume3
Issue number4
DOIs
Publication statusPublished - Dec 2022

Keywords

  • Bing–Neel syndrome
  • BTK inhibitors
  • central nervous system involvement
  • ibrutinib
  • lymphoplasmacytic lymphoma
  • orbital involvement
  • Waldenström macroglobulinaemia

Fingerprint

Dive into the research topics of 'Bing–Neel Syndrome: Update on Diagnosis and Treatment'. Together they form a unique fingerprint.

Cite this